Vallon Pharmaceuticals Announces Appointment of Meenu Karson to Board of Directors
28 févr. 2022 16h05 HE
|
Vallon Pharmaceuticals Inc.
Global biopharmaceutical industry senior executive with over 15 years of operational leadership with transactional and capital markets experience spanning both private and public large pharma and...
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of SBPH, NTN, PTI and GLIBA Mergers
23 sept. 2020 15h00 HE
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., Sept. 23, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Spring Bank Pharmaceuticals, Inc. (NASDAQ GS: SBPH) regarding possible breaches...
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of BMCH, BYFC, CGIX, and PTI Mergers
02 sept. 2020 20h00 HE
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: BMC Stock Holdings, Inc. (NASDAQ GS: BMCH) regarding possible breaches of...
Proteostasis Therapeutics Announces Scientific Presentations on New Data at 30th Annual North American Cystic Fibrosis Conference
22 sept. 2016 07h30 HE
|
Proteostasis Therapeutics, Inc
CAMBRIDGE, Mass., Sept. 22, 2016 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by...
Proteostasis Therapeutics Announces Closing of Follow-On Public Offering of Common Stock
14 sept. 2016 16h03 HE
|
Proteostasis Therapeutics, Inc
CAMBRIDGE, Mass., Sept. 14, 2016 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused...
Proteostasis Therapeutics Announces Pricing of Public Offering of Common Stock
09 sept. 2016 07h30 HE
|
Proteostasis Therapeutics, Inc
CAMBRIDGE, Mass., Sept. 09, 2016 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by...
Proteostasis Therapeutics Issues Mid-Year Corporate Update on Cystic Fibrosis Pipeline Programs
11 août 2016 07h45 HE
|
Proteostasis Therapeutics, Inc
CAMBRIDGE, Mass., Aug. 11, 2016 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by...